244 related articles for article (PubMed ID: 19178673)
1. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
2. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
[TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
[TBL] [Abstract][Full Text] [Related]
7. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
Sottnik JL; Thamm DH
Vet Comp Oncol; 2010 Jun; 8(2):96-102. PubMed ID: 20579322
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
Korkeila EA; Sundström J; Pyrhönen S; Syrjänen K
Anticancer Res; 2011 Dec; 31(12):4529-35. PubMed ID: 22199327
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological relevance of tumour grading in canine osteosarcoma.
Loukopoulos P; Robinson WF
J Comp Pathol; 2007 Jan; 136(1):65-73. PubMed ID: 17270206
[TBL] [Abstract][Full Text] [Related]
14. GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
Ahrens WA; Ridenour RV; Caron BL; Miller DV; Folpe AL
Hum Pathol; 2008 Oct; 39(10):1519-26. PubMed ID: 18620729
[TBL] [Abstract][Full Text] [Related]
15. Expression of connexins in normal and neoplastic canine bone tissue.
Sanches DS; Pires CG; Fukumasu H; Cogliati B; Matsuzaki P; Chaible LM; Torres LN; Ferrigno CR; Dagli ML
Vet Pathol; 2009 Sep; 46(5):846-59. PubMed ID: 19429987
[TBL] [Abstract][Full Text] [Related]
16. Relations of TGF-beta1 with HIF-1 alpha, GLUT-1 and longer survival of colorectal cancer patients.
Sulkowska M; Wincewicz A; Sulkowski S; Koda M; Kanczuga-Koda L
Pathology; 2009; 41(3):254-60. PubMed ID: 19142800
[TBL] [Abstract][Full Text] [Related]
17. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
Chen Y; Wang CM; Shi YQ; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
Endo M; Tateishi U; Seki K; Yamaguchi U; Nakatani F; Kawai A; Chuman H; Beppu Y
Jpn J Clin Oncol; 2007 Dec; 37(12):955-60. PubMed ID: 18211986
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.
Selvarajah GT; Verheije MH; Kik M; Slob A; Rottier PJ; Mol JA; Kirpensteijn J
Vet J; 2012 Aug; 193(2):412-9. PubMed ID: 22436430
[TBL] [Abstract][Full Text] [Related]
20. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]